openPR Logo
Press release

Global Metagenomics Market Projected to Surpass $4 Billion by 2029 with 15% Annual Growth

03-03-2025 08:50 AM CET | Health & Medicine

Press release from: The Business Research Company

Metagenomics Market Size

Metagenomics Market Size

What market dynamics are playing a key role in accelerating the growth of the metagenomics market?
The metagenomics market is experiencing substantial growth, largely due to the escalating occurrence of infectious diseases. These diseases, otherwise referred to as transmissible diseases, are illnesses propagated by harmful microorganisms, such as bacteria, viruses, fungi, and parasites. They can be passed from one person to another or through different transmission methods. Metagenomics lends a hand in the investigation of these diseases by scrutinizing the genetic makeup of microbial communities. It enables a thorough analysis of microbial communities linked to infectious agents, offering an understanding of their structure, genetic variety, and probable interactions. For example, a report by the UK Health Security Agency, a government agency based in the UK, noted in February 2024 that tuberculosis (TB) incidents in England surged by 10.7% in 2023, accounting for 4,850 cases as against 4,380 in 2022. As a result, the mounting prevalence of infectious diseases is fueling the expansion of the metagenomics market.

Get Your Metagenomics Market Report Here:
https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

How will the growth rate of the metagenomics market shape industry trends by 2034?
The size of the metagenomics market has experienced considerable growth in the past few years, escalating from $2.01 billion in 2024 to an expected $2.32 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.4%. Factors contributing to this growth during the historical period include advancements in microbiome research, studies related to disease association, needs for environmental surveillance, usage in agriculture and food applications, and processes in biotechnology and industry.

The size of the metagenomics market is anticipated to experience accelerated expansion in the subsequent years, escalating to $4 billion in 2029 with a compound annual growth rate (CAGR) of 14.7%. The surge during the forecast period can be linked to factors like the incorporation of precision medicine, comprehension of microbial ecology, one health campaigns, bioprospecting alongside drug discovery, along with diagnostic and therapeutic revolutions. The forecast period is also expected to see key trends like technological evolution in sequencing, amalgamation of artificial intelligence and machine learning, single-cell metagenomics, normalization of metagenomic data, as well as consumer wellness and customized nutrition.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10815&type=smp

What trends are poised to drive the future success of the metagenomics market?
The main trend currently being witnessed in the metagenomics market is a result of tech advancements. This has led to a large number of leading companies in the metagenomics market focusing on adoption of new genomics technologies to boost their powers of observation and fortify their market position. For example, in May 2023, the US-genomics services company, CD Genomics, introduced its Long-Read Metagenomic Sequencing service. Using the latest technology, this service enables researchers and scientists to delve deeper into the complicated area of microbial communities with an incredible level of accuracy and depth. By making the most of CD Genomics' state-of-the-art technology and genomic knowledge, clients can now step into a new age of metagenomics research. The essential features of this service include improved resolution, species identification, functional annotation and comparative analysis. The introduction of this advanced method is set to revolutionize metagenomics research by providing unprecedented insights into microbial communities.

Which primary segments of the metagenomics market are driving growth and industry transformations?
The metagenomics market covered in this report is segmented -

1) By Product: Instruments, Kits And Reagents, Software And Services
2) By Workflow: Sequencing, Pre-Sequencing, Data Analysis
3) By Application: Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food And Nutrition, Other Applications
4) By End User: Pharmaceutical Industries, Research Laboratories, Biotechnology Companies, Pathology Laboratories, Academic And Research Institutes

Subsegments:
1) By Instruments: DNA Sequencers, PCR Machines, Microarray Systems, Mass Spectrometers
2) By Kits And Reagents: DNA Extraction Kits, Library Preparation Kits, Amplification Kits, Sequencing Reagents
3) By Software And Services: Data Analysis Software, Bioinformatics Services, Cloud-Based Data Storage, Consultation Services

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10815

Which geographical regions are pioneering growth in the metagenomics market?
North America was the largest region in the global metagenomics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the metagenomics market landscape?
Major companies operating in the metagenomics market include Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10815&type=smp

What Is Covered In The Metagenomics Global Market Report?

• Market Size Forecast: Examine the metagenomics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the metagenomics market for a structured understanding.
• Key Players Overview: Analyze major players in the metagenomics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the metagenomics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the metagenomics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the metagenomics market.
• Industry Challenges: Identify potential risks and obstacles affecting the metagenomics market.
• Competitive Landscape: Review strategic developments in the metagenomics market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Metagenomics Market Projected to Surpass $4 Billion by 2029 with 15% Annual Growth here

News-ID: 3893831 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Metagenomi

Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) should contact t …
An investigation on behalf of current long-term investors in shares of Metagenomi, Inc. (NASDAQ: MGX) concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc. was announced. Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Investigation announced for Long Term Investors in shares of Metagenomi, Inc. (N …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc. Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: MGX stocks follows a lawsuit filed against Metagenomi, Inc. over
Trump's "Stargate AI" Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
In a world where healthcare innovation is accelerating, companies leveraging artificial intelligence are leading the charge in transforming patient care, diagnostics, and therapeutic solutions. Their advancements in smart disinfection, AI-designed therapies, precision gene editing, and cardiovascular diagnostics are not only reshaping their industries but also unlocking tremendous growth potential. Here's how these cutting-edge companies are redefining the future of healthcare. CS Diagnostics Corp. (OTCQB: CSDX) Launches Next-Gen Disinfectant MEDUSA a cutting-edge
Lawsuit filed for Investors who lost money with shares of Metagenomi, Inc. (NASD …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 25, 2024. NASDAQ: MGX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Lawsuit filed for Investors who lost money with Metagenomi, Inc. (NASDAQ: MGX) i …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements made between February 9 and 13, 2024. Investors who purchased a significant amount of shares of Metagenomi, Inc. (NASDAQ: MGX) between February 9 and 13, 2024, have certain options and for certain investors are short and strict deadlines running.
Investigation announced for Investors in shares of Metagenomi, Inc. (NASDAQ: MGX …
An investigation was announced for investors of Metagenomi, Inc. (NASDAQ: MGX) shares over potential securities laws violations by Metagenomi, Inc. Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Metagenomi, Inc. (NASDAQ: MGX) concerning whether a series